According to Ensysce Biosciences's latest financial reports the company has NZ$6.15 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | NZ$6.2 M | 249.5% |
2023-12-31 | NZ$1.77 M | -64.16% |
2022-12-31 | NZ$4.95 M | -72.39% |
2021-12-31 | NZ$17.95 M | 6571% |
2020-12-31 | NZ$0.26 M |